マルチプレックスアッセイの世界市場2021-2028

【英語タイトル】GLOBAL MULTIPLEX ASSAY MARKET FORECAST 2021-2028

Inkwood Researchが出版した調査資料(INK21N024)・商品コード:INK21N024
・発行会社(調査会社):Inkwood Research
・発行日:2021年7月
・ページ数:240
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥666,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

本市場調査レポートでは、マルチプレックスアッセイの世界市場について調査・分析し、調査範囲・手法、エグゼクティブサマリー、市場動向、主要分析、種類別(タンパク質ベースマルチプレックスアッセイ、核酸ベースマルチプレックスアッセイ、その他マルチプレックスアッセイ)分析、製品別(試薬・消耗品、機器・付属品、ソフトウェア・サービス)分析、技術別(マルチプレックスタンパク質マイクロアレイ、マルチプレックスPCR、その他)分析、用途別(臨床診断、研究開発、コンパニオン診断)分析、地域別分析、競争状況などの項目を掲載しています。
・調査範囲・手法
・エグゼクティブサマリー
・市場動向
・主要分析
・マルチプレックスアッセイの世界市場規模:種類別(タンパク質ベースマルチプレックスアッセイ、核酸ベースマルチプレックスアッセイ、その他マルチプレックスアッセイ)
・マルチプレックスアッセイの世界市場規模:製品別(試薬・消耗品、機器・付属品、ソフトウェア・サービス)
・マルチプレックスアッセイの世界市場規模:技術別(マルチプレックスタンパク質マイクロアレイ、マルチプレックスPCR、その他)
・マルチプレックスアッセイの世界市場規模:用途別(臨床診断、研究開発、コンパニオン診断)
・マルチプレックスアッセイの世界市場規模:地域別
・競争状況

KEY FINDINGS
The global multiplex assay market is forecasted to register a CAGR of 8.74% over the estimated period of 2021 to 2028. The market growth is facilitated by key factors like increased government funding as well as research and development activities, the growing preference of multiplex assays over conventional assays, and the growing adoption of personalized medicines.

MARKET INSIGHTS
A multiplex assay is a procedure in which several analytes, including proteins, cytokines, biomolecules, growth factors, chemokines, and others are profiled by detecting and quantifying them simultaneously. The assay is utilized to amplify multiple targets in a polymerase chain reaction (PCR) and gather added information from minute quantities of proteins or other analytes in lesser time compared to traditional methods like ELISA.
Multiplex assays hold tremendous potential in the research and development of drugs for the treatment of diseases, such as cancer and cardiovascular diseases. For instance, bead-based Luminex xMAP multiplex assay offers a platform for cancer biomarker assays compatible with plasma, cultured cells, serum, as well as other biological samples. The American Association of Cancer Research (AACR) designed the multiplex immunoassay that assisted in the examination of acquired resistance to receptor tyrosine kinase (RTK) inhibitors. Moreover, RTK is utilized as a target for drug development to treat cancer.

REGIONAL INSIGHTS
The global multiplex assay market growth assessment includes the analysis of North America, Europe, the Asia-Pacific, and the Rest of World. North America is set to harbor the highest market share by the end of the forecast period. The market growth is attributed to key drivers such as the increasing research and development activities of new drugs as well as treatment options, the rise in government funds for detecting new biomarkers, and the growing incidence of chronic conditions like stroke and cancer.

COMPETITIVE INSIGHTS
The intensity of competitive rivalry within the global multiplex assay market is anticipated to remain high over the projected years. Companies in the market adopt several strategies, including new product developments, mergers and acquisitions, and collaborations in order to compete and retain their market share. The trend continues to remain the same due to the entrance of new firms as well as the rising adoption of multiplex assay technology, anticipated to generate new opportunities in the global market.
Some of the leading firms operating in the market include F. Hoffmann-la Roche, Agilent Technologies Inc, Qiagen NV, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

❖ レポートの目次 ❖

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GOVERNMENTAL FUNDING AND R&D ACTIVITIES
3.1.2. PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
3.1.3. ADOPTION OF PERSONALIZED MEDICINES
3.2. KEY RESTRAINTS
3.2.1. UNAVAILABILITY OF SKILLED LAB TECHNICIANS
3.2.2. COMPLIANCE WITH STRICT ENVIRONMENTAL REGULATIONS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. KEY BUYING CRITERIA
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE
5. MARKET BY TYPE
5.1. PROTEIN-BASED MULTIPLEX ASSAY
5.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
5.3. OTHER MULTIPLEX ASSAYS
6. MARKET BY PRODUCT
6.1. REAGENTS AND CONSUMABLES
6.2. INSTRUMENTS AND ACCESSORIES
6.3. SOFTWARE AND SERVICES
7. MARKET BY TECHNOLOGY
7.1. MULTIPLEX PROTEIN MICROARRAY
7.2. MULTIPLEX PCR
7.3. OTHER TECHNOLOGIES
8. MARKET BY APPLICATION
8.1. CLINICAL DIAGNOSTICS
8.2. RESEARCH AND DEVELOPMENT
8.3. COMPANION DIAGNOSTICS
9. MARKET BY END-USER
9.1. HOSPITALS
9.2. CLINICAL LABORATORIES
9.3. RESEARCH INSTITUTES
9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10. GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. KEY GROWTH ENABLERS
10.1.3. KEY CHALLENGES
10.1.4. KEY PLAYERS
10.1.5. COUNTRY ANALYSIS
10.1.5.1. UNITED STATES
10.1.5.2. CANADA
10.2. EUROPE
10.2.1. MARKET SIZE & ESTIMATES
10.2.2. KEY GROWTH ENABLERS
10.2.3. KEY CHALLENGES
10.2.4. KEY PLAYERS
10.2.5. COUNTRY ANALYSIS
10.2.5.1. GERMANY
10.2.5.2. FRANCE
10.2.5.3. UNITED KINGDOM
10.2.5.4. ITALY
10.2.5.5. RUSSIA
10.2.5.6. BELGIUM
10.2.5.7. POLAND
10.2.5.8. REST OF EUROPE
10.3. ASIA-PACIFIC
10.3.1. MARKET SIZE & ESTIMATES
10.3.2. KEY GROWTH ENABLERS
10.3.3. KEY CHALLENGES
10.3.4. KEY PLAYERS
10.3.5. COUNTRY ANALYSIS
10.3.5.1. CHINA
10.3.5.2. JAPAN
10.3.5.3. INDIA
10.3.5.4. AUSTRALIA & NEW ZEALAND
10.3.5.5. SOUTH KOREA
10.3.5.6. THAILAND
10.3.5.7. INDONESIA
10.3.5.8. VIETNAM
10.3.5.9. REST OF ASIA-PACIFIC
10.4. REST OF WORLD
10.4.1. MARKET SIZE & ESTIMATES
10.4.2. KEY GROWTH ENABLERS
10.4.3. KEY CHALLENGES
10.4.4. KEY PLAYERS
10.4.5. REGIONAL ANALYSIS
10.4.5.1. LATIN AMERICA
10.4.5.2. MIDDLE EAST & AFRICA
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
11.2. COMPANY PROFILES
11.2.1. ABCAM
11.2.2. AGILENT TECHNOLOGIES INC
11.2.3. BECTON, DICKINSON AND COMPANY (BD)
11.2.4. BIO-RAD LABORATORIES INC
11.2.5. BIO-TECHNE CORPORATION
11.2.6. F. HOFFMANN-LA ROCHE
11.2.7. ILLUMINA INC
11.2.8. LUMINEX CORPORATION
11.2.9. MERCK MILLIPORE
11.2.10. OLINK PROTEOMICS AB
11.2.11. QIAGEN NV
11.2.12. RANDOX LABORATORIES LTD
11.2.13. SEEGENE INC
11.2.14. SIEMENS HEALTHINEERS AG
11.2.15. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - MULTIPLEX ASSAY
TABLE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL OTHER MULTIPLEX ASSAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: GLOBAL OTHER MULTIPLEX ASSAYS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: GLOBAL MULTIPLEX PCR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 23: GLOBAL MULTIPLEX PCR MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 24: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 25: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 26: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 27: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 28: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 29: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 30: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 31: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 32: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 33: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 34: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 35: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 36: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 37: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 38: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 39: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 40: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 41: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 42: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 43: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 44: GLOBAL MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 45: GLOBAL MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 46: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 47: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 48: LEADING PLAYERS OPERATING IN THE NORTH AMERICA MULTIPLEX ASSAY MARKET
TABLE 49: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 50: EUROPE MULTIPLEX ASSAY, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 51: LEADING PLAYERS OPERATING IN EUROPE MULTIPLEX ASSAY MARKET
TABLE 52: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 53: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 54: LEADING PLAYERS OPERATING IN ASIA-PACIFIC MULTIPLEX ASSAY MARKET
TABLE 55: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 56: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 57: LEADING PLAYERS OPERATING IN REST OF WORLD MULTIPLEX ASSAY MARKET
TABLE 58: LIST OF MERGERS & ACQUISITIONS
TABLE 59: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 60: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 61: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020
FIGURE 6: GLOBAL MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020
FIGURE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020
FIGURE 14: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)
FIGURE 16: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
FIGURE 17: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020
FIGURE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020
FIGURE 23: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 24: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 25: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 26: GLOBAL MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 27: NORTH AMERICA MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 28: UNITED STATES MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: CANADA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: EUROPE MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 31: GERMANY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: FRANCE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 33: UNITED KINGDOM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: ITALY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: RUSSIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: BELGIUM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: POLAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: REST OF EUROPE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 39: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 40: CHINA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 41: JAPAN MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 42: INDIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 43: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 44: SOUTH KOREA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 45: THAILAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 46: INDONESIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 47: VIETNAM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 48: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 49: REST OF WORLD MULTIPLEX ASSAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 50: LATIN AMERICA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 51: MIDDLE EAST & AFRICA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)


★調査レポート[マルチプレックスアッセイの世界市場2021-2028] (コード:INK21N024)販売に関する免責事項を必ずご確認ください。
★調査レポート[マルチプレックスアッセイの世界市場2021-2028]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆